312 related articles for article (PubMed ID: 33053898)
1. Therapeutic Perspectives of Adenosine Deaminase Inhibition in Cardiovascular Diseases.
Kutryb-Zajac B; Mierzejewska P; Slominska EM; Smolenski RT
Molecules; 2020 Oct; 25(20):. PubMed ID: 33053898
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of LPS-stimulated ecto-adenosine deaminase attenuates endothelial cell activation.
Kutryb-Zajac B; Mierzejewska P; Sucajtys-Szulc E; Bulinska A; Zabielska MA; Jablonska P; Serocki M; Koszalka P; Milczarek R; Jasztal A; Bartoszewski R; Chlopicki S; Slominska EM; Smolenski RT
J Mol Cell Cardiol; 2019 Mar; 128():62-76. PubMed ID: 30641086
[TBL] [Abstract][Full Text] [Related]
3. Increased activity of vascular adenosine deaminase in atherosclerosis and therapeutic potential of its inhibition.
Kutryb-Zajac B; Mateuszuk L; Zukowska P; Jasztal A; Zabielska MA; Toczek M; Jablonska P; Zakrzewska A; Sitek B; Rogowski J; Lango R; Slominska EM; Chlopicki S; Smolenski RT
Cardiovasc Res; 2016 Nov; 112(2):590-605. PubMed ID: 28513806
[TBL] [Abstract][Full Text] [Related]
4. Phenolic compounds as potential adenosine deaminase inhibitors: molecular docking and dynamics simulation coupled with MM-GBSA calculations.
Uba AI; Paradis NJ; Wu C; Zengin G
Amino Acids; 2023 Dec; 55(12):1729-1743. PubMed ID: 37517044
[TBL] [Abstract][Full Text] [Related]
5. Understanding the mode of inhibition and molecular interaction of taxifolin with human adenosine deaminase.
Rawat RS; Kumar S
J Biomol Struct Dyn; 2023 Feb; 41(2):377-385. PubMed ID: 34851227
[TBL] [Abstract][Full Text] [Related]
6. Effect of deoxycoformycin and Val-boroPro on the associated catalytic activities of lymphocyte CD26 and ecto-adenosine deaminase.
Jeanfavre DD; Woska JR; Pargellis CA; Kennedy CA; Prendergast J; Stearns C; Reilly PL; Barton RW; Bormann BJ
Biochem Pharmacol; 1996 Dec; 52(11):1757-65. PubMed ID: 8986139
[TBL] [Abstract][Full Text] [Related]
7. Enzymatic and extraenzymatic role of ecto-adenosine deaminase in lymphocytes.
Franco R; Valenzuela A; Lluis C; Blanco J
Immunol Rev; 1998 Feb; 161():27-42. PubMed ID: 9553762
[TBL] [Abstract][Full Text] [Related]
8. Computational and experimental validation of morin as adenosine deaminase inhibitor.
Arun KG; Sharanya CS; Sadasivan C
J Recept Signal Transduct Res; 2018 Jun; 38(3):240-245. PubMed ID: 29843562
[TBL] [Abstract][Full Text] [Related]
9. Molecular Evidence of Adenosine Deaminase Linking Adenosine A
Moreno E; Canet J; Gracia E; Lluís C; Mallol J; Canela EI; Cortés A; Casadó V
Front Pharmacol; 2018; 9():106. PubMed ID: 29497379
[TBL] [Abstract][Full Text] [Related]
10. Development of a Simple Assay Method for Adenosine Deaminase via Enzymatic Formation of an Inosine-Tb
Lee S; Park H; Ki Y; Lee H; Han MS
Sensors (Basel); 2019 Jun; 19(12):. PubMed ID: 31216643
[TBL] [Abstract][Full Text] [Related]
11. Regulation of adenosine receptor engagement by ecto-adenosine deaminase.
Hashikawa T; Hooker SW; Maj JG; Knott-Craig CJ; Takedachi M; Murakami S; Thompson LF
FASEB J; 2004 Jan; 18(1):131-3. PubMed ID: 14630704
[TBL] [Abstract][Full Text] [Related]
12. Adenosine deaminase: functional implications and different classes of inhibitors.
Cristalli G; Costanzi S; Lambertucci C; Lupidi G; Vittori S; Volpini R; Camaioni E
Med Res Rev; 2001 Mar; 21(2):105-28. PubMed ID: 11223861
[TBL] [Abstract][Full Text] [Related]
13. Adenosine deaminase inhibition.
Bagheri S; Saboury AA; Haertlé T
Int J Biol Macromol; 2019 Dec; 141():1246-1257. PubMed ID: 31520704
[TBL] [Abstract][Full Text] [Related]
14. Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders.
Antonioli L; Colucci R; La Motta C; Tuccori M; Awwad O; Da Settimo F; Blandizzi C; Fornai M
Curr Drug Targets; 2012 Jun; 13(6):842-62. PubMed ID: 22250650
[TBL] [Abstract][Full Text] [Related]
15. Distribution and expression of A1 adenosine receptors, adenosine deaminase and adenosine deaminase-binding protein (CD26) in goldfish brain.
Beraudi A; Traversa U; Villani L; Sekino Y; Nagy JI; Poli A
Neurochem Int; 2003 May; 42(6):455-64. PubMed ID: 12547644
[TBL] [Abstract][Full Text] [Related]
16. Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response.
Dong RP; Kameoka J; Hegen M; Tanaka T; Xu Y; Schlossman SF; Morimoto C
J Immunol; 1996 Feb; 156(4):1349-55. PubMed ID: 8568233
[TBL] [Abstract][Full Text] [Related]
17. Does adenosine deaminase play a key role in coronary artery disease.
Tang R; Ma C; Dong J; Liu X; Liu X
Med Hypotheses; 2006; 67(2):371-4. PubMed ID: 16600525
[TBL] [Abstract][Full Text] [Related]
18. Moonlighting adenosine deaminase: a target protein for drug development.
Cortés A; Gracia E; Moreno E; Mallol J; Lluís C; Canela EI; Casadó V
Med Res Rev; 2015 Jan; 35(1):85-125. PubMed ID: 24933472
[TBL] [Abstract][Full Text] [Related]
19. Probing inhibition mechanisms of adenosine deaminase by using molecular dynamics simulations.
Tian X; Liu Y; Zhu J; Yu Z; Han J; Wang Y; Han W
PLoS One; 2018; 13(11):e0207234. PubMed ID: 30444912
[TBL] [Abstract][Full Text] [Related]
20. Expression of ecto-adenosine deaminase and CD26 in human T cells triggered by the TCR-CD3 complex. Possible role of adenosine deaminase as costimulatory molecule.
Martín M; Huguet J; Centelles JJ; Franco R
J Immunol; 1995 Nov; 155(10):4630-43. PubMed ID: 7594462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
